Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 03, 2015 9:40 AM ET

Pharmaceuticals

Company Overview of vasopharm GmbH

Company Overview

vasopharm GmbH, a pharmaceutical company, engages in the discovery and development of therapeutics for the treatment of cerebro and cardiovascular diseases, and their consequences. Its therapeutic pipeline VAS203, an allosteric nitric oxide synthase inhibitor interacting with the BH4 binding site of the enzyme; and VAS2870, a NAD(P)H oxidase (NOX) modulator for the treatment of peripheral arterial occlusive diseases. The company was founded in 1998 and is based in Wuerzburg, Germany.

Friedrich-Bergius-Ring 15

Wuerzburg,  97076

Germany

Founded in 1998

Phone:

49 931 35 90 99 0

Fax:

49 931 35 90 99 12

Key Executives for vasopharm GmbH

Co-Founder and Chief Executive Officer
Co-Founder
Head of Chemistry & Manufacturing
Chief Technology Officer
Compensation as of Fiscal Year 2014.

vasopharm GmbH Key Developments

vasopharm GmbH Presents at BIO-Europe 2014, Nov-03-2014 05:15 PM

vasopharm GmbH Presents at BIO-Europe 2014, Nov-03-2014 05:15 PM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Christian Wandersee, CEO.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact vasopharm GmbH, please visit www.vasopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.